Cargando…
A Novel APOC2 Mutation in a Colombian Patient with Recurrent Hypertriglyceridemic Pancreatitis
Hypertriglyceridemia is a common disease with only 2% of cases exhibiting monogenic mutations. Familial chylomicronemia syndrome (FCS) is a rare genetic condition associated with recurrent and severe episodes of pancreatitis and is mainly caused by mutations in the LPL gene, with few cases related t...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7125404/ https://www.ncbi.nlm.nih.gov/pubmed/32280258 http://dx.doi.org/10.2147/TACG.S243148 |
_version_ | 1783515937007206400 |
---|---|
author | Pinilla-Monsalve, Gabriel D Lores, Juliana Pachajoa, Harry López-Ponce de León, Juan D López, Alejandro Rodríguez-Rojas, Lisa X Nastasi-Catanese, José A |
author_facet | Pinilla-Monsalve, Gabriel D Lores, Juliana Pachajoa, Harry López-Ponce de León, Juan D López, Alejandro Rodríguez-Rojas, Lisa X Nastasi-Catanese, José A |
author_sort | Pinilla-Monsalve, Gabriel D |
collection | PubMed |
description | Hypertriglyceridemia is a common disease with only 2% of cases exhibiting monogenic mutations. Familial chylomicronemia syndrome (FCS) is a rare genetic condition associated with recurrent and severe episodes of pancreatitis and is mainly caused by mutations in the LPL gene, with few cases related to abnormal function of apolipoprotein C-II. This is a 50-year-old female with a past medical history of arterial hypertension, miscarriage and recurrent pancreatitis. In the last four years, her triglycerides and lipase concentration reached >3000 mg/dL and >700 U/L, respectively. The patient was not responsive to statins, fibrates, or tetrahydrolipstatin. A novel homozygous frameshift mutation on exon 3 of the APOC2 gene was detected, c.133_134delTC. Subsequent Sanger sequencing confirmed that three first-degree relatives were carriers of the same mutation. To the best of our knowledge, we are reporting the first Colombian patient with FCS due to an APOC2 mutation. We propose that this mutation caused recurrent hypertriglyceridemic pancreatitis. |
format | Online Article Text |
id | pubmed-7125404 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-71254042020-04-10 A Novel APOC2 Mutation in a Colombian Patient with Recurrent Hypertriglyceridemic Pancreatitis Pinilla-Monsalve, Gabriel D Lores, Juliana Pachajoa, Harry López-Ponce de León, Juan D López, Alejandro Rodríguez-Rojas, Lisa X Nastasi-Catanese, José A Appl Clin Genet Case Report Hypertriglyceridemia is a common disease with only 2% of cases exhibiting monogenic mutations. Familial chylomicronemia syndrome (FCS) is a rare genetic condition associated with recurrent and severe episodes of pancreatitis and is mainly caused by mutations in the LPL gene, with few cases related to abnormal function of apolipoprotein C-II. This is a 50-year-old female with a past medical history of arterial hypertension, miscarriage and recurrent pancreatitis. In the last four years, her triglycerides and lipase concentration reached >3000 mg/dL and >700 U/L, respectively. The patient was not responsive to statins, fibrates, or tetrahydrolipstatin. A novel homozygous frameshift mutation on exon 3 of the APOC2 gene was detected, c.133_134delTC. Subsequent Sanger sequencing confirmed that three first-degree relatives were carriers of the same mutation. To the best of our knowledge, we are reporting the first Colombian patient with FCS due to an APOC2 mutation. We propose that this mutation caused recurrent hypertriglyceridemic pancreatitis. Dove 2020-03-26 /pmc/articles/PMC7125404/ /pubmed/32280258 http://dx.doi.org/10.2147/TACG.S243148 Text en © 2020 Pinilla-Monsalve et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Case Report Pinilla-Monsalve, Gabriel D Lores, Juliana Pachajoa, Harry López-Ponce de León, Juan D López, Alejandro Rodríguez-Rojas, Lisa X Nastasi-Catanese, José A A Novel APOC2 Mutation in a Colombian Patient with Recurrent Hypertriglyceridemic Pancreatitis |
title | A Novel APOC2 Mutation in a Colombian Patient with Recurrent Hypertriglyceridemic Pancreatitis |
title_full | A Novel APOC2 Mutation in a Colombian Patient with Recurrent Hypertriglyceridemic Pancreatitis |
title_fullStr | A Novel APOC2 Mutation in a Colombian Patient with Recurrent Hypertriglyceridemic Pancreatitis |
title_full_unstemmed | A Novel APOC2 Mutation in a Colombian Patient with Recurrent Hypertriglyceridemic Pancreatitis |
title_short | A Novel APOC2 Mutation in a Colombian Patient with Recurrent Hypertriglyceridemic Pancreatitis |
title_sort | novel apoc2 mutation in a colombian patient with recurrent hypertriglyceridemic pancreatitis |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7125404/ https://www.ncbi.nlm.nih.gov/pubmed/32280258 http://dx.doi.org/10.2147/TACG.S243148 |
work_keys_str_mv | AT pinillamonsalvegabrield anovelapoc2mutationinacolombianpatientwithrecurrenthypertriglyceridemicpancreatitis AT loresjuliana anovelapoc2mutationinacolombianpatientwithrecurrenthypertriglyceridemicpancreatitis AT pachajoaharry anovelapoc2mutationinacolombianpatientwithrecurrenthypertriglyceridemicpancreatitis AT lopezponcedeleonjuand anovelapoc2mutationinacolombianpatientwithrecurrenthypertriglyceridemicpancreatitis AT lopezalejandro anovelapoc2mutationinacolombianpatientwithrecurrenthypertriglyceridemicpancreatitis AT rodriguezrojaslisax anovelapoc2mutationinacolombianpatientwithrecurrenthypertriglyceridemicpancreatitis AT nastasicatanesejosea anovelapoc2mutationinacolombianpatientwithrecurrenthypertriglyceridemicpancreatitis AT pinillamonsalvegabrield novelapoc2mutationinacolombianpatientwithrecurrenthypertriglyceridemicpancreatitis AT loresjuliana novelapoc2mutationinacolombianpatientwithrecurrenthypertriglyceridemicpancreatitis AT pachajoaharry novelapoc2mutationinacolombianpatientwithrecurrenthypertriglyceridemicpancreatitis AT lopezponcedeleonjuand novelapoc2mutationinacolombianpatientwithrecurrenthypertriglyceridemicpancreatitis AT lopezalejandro novelapoc2mutationinacolombianpatientwithrecurrenthypertriglyceridemicpancreatitis AT rodriguezrojaslisax novelapoc2mutationinacolombianpatientwithrecurrenthypertriglyceridemicpancreatitis AT nastasicatanesejosea novelapoc2mutationinacolombianpatientwithrecurrenthypertriglyceridemicpancreatitis |